It has been shown that DHA/EPA-enriched membranes can disrupt the lipid raft structure in cancer cell membranes, leading to the depolymerization of the epidermal growth factor receptor (EGFR) from the lipid rafts and impairing the activity of its downstream signaling pathways (58). The gene discussed is EGFR; the disease is cancer.